For the first time, clinical trial results show Ebola drugs improve survival rates
A historic clinical trial has shown that two therapies made from Ebola antibodies appear to be improving survival rates among people who receive them, health officials announced Monday. The announcement marks the first time a clinical trial has successfully shown that an Ebola therapy improves survival in people who have been infected.
Two other therapies used in the clinical trial performed less well and will be discontinued.
